Two-color coincidence single-molecule pull-down for the specific detection of disease-associated protein aggregates
Saleeb, R. S.; Leighton, C.; Lee, J.-E.; O'Shaughnessy, J.; Jeacock, K.; Chappard, A.; Cumberland, R.; Ball, S. R.; Sunde, M.; Clarke, D. J.; Piche, K.; McPhail, J. A.; Louwrier, A.; Angers, R.; Gandhi, S.; Downey, P.; Kunath, T.; Horrocks, M. H.
Show abstract
The misfolding and aggregation of protein is a characteristic of many neurodegenerative disorders, including Alzheimers and Parkinsons disease. The wide range of sizes and structures of oligomers and fibrils generated have previously been studied using single-molecule and super-resolution microscopy. These methods, however, tend to rely on the use of either directly labeled protein, or on the addition of non-specific amyloid stains, such as thioflavin-T. This has prevented the characterization of protein aggregate composition in complex biological samples. Here, we have developed a single-molecule two-color aggregate pull-down (STAPull) assay to overcome this challenge by probing immobilized proteins using orthogonally labeled antibodies targeting the same epitope. By looking at colocalized signals, we can eliminate monomeric protein, and specifically quantify aggregated proteins. Using the aggregation-prone alpha-synuclein protein as a model, we demonstrate that this approach can specifically detect aggregates with a limit of detection of 5 pM. Furthermore, we show that STAPull can be used in a range of samples, including in human biofluids. STAPull is generally applicable to protein aggregates from a variety of disorders, and will aid in the identification of biomarkers that are crucial in the effort to diagnose these diseases.
Matching journals
The top 3 journals account for 50% of the predicted probability mass.
Similar papers in this journal
- MJF-14 proximity ligation assay detects early non-inclusion alpha-synuclein pathology with enhanced specificity and sensitivity 96%
- Novel tools to quantify total, phospho-Ser129 and aggregated alpha-synuclein in the mouse brain 96%
- A brain-shuttled antibody targeting alpha synuclein aggregates for the treatment of synucleinopathies 95%
Similar papers in this journal
- Endo-lysosomal Aβ concentration and pH enable formation of Aβ oligomers that potently induce Tau missorting 96%
- Modeling Alpha-Synuclein Pathology in a Human Brain-Chip to Assess Blood-Brain Barrier Disruption in Parkinson's Disease 95%
- The extracellular chaperone Clusterin enhances Tau aggregate seeding in a cellular model 95%
Similar papers in this journal
- Single molecule fingerprinting reveals different amplification properties of α-synuclein oligomers and preformed fibrils in seeding assay. 94%
- Disease associated mutations in tau encode for changes in aggregate structure conformation 94%
- Fast purification of recombinant monomeric amyloid-β from E. coli and amyloid-β-mCherry aggregates from mammalian cells 93%
Similar papers in this journal
"Similar papers" are the closest papers from that journal in the model's embedding space. They show what the match is built on, but the ranking comes mostly from a classifier over the whole training set, not from these examples alone.